FDA issues new safety alert on Reumofan Plus and Reumofan Plus Premium
date:Aug 22, 2012
us Premium for drug and disease interactions involving diclofenac, methocarbamol, and corticosteroids, and consider whether a corticosteroid taper regimen may be appropriate.
7/7 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/01 21:10